Cupid Limited has completed the allotment of 107,57,28,560 fully paid-up bonus equity shares, marking a significant corporate action for the condom and healthcare products manufacturer. The Board of Directors approved this allotment through a circular resolution on March 10, 2026, following the established record date of March 9, 2026.

Bonus Share Allotment Details

The bonus shares were issued in a 4:1 proportion, meaning shareholders received 4 new fully paid-up equity shares of Re. 1 each for every 1 existing fully paid-up equity share held. The allotment was made to eligible shareholders whose names appeared in the Register of Shareholders or the List of Beneficial Owners maintained by the Depositories as on the record date.

Impact on Share Capital Structure

The bonus issue has resulted in a substantial increase in the company's paid-up equity share capital. The transformation reflects the company's commitment to rewarding shareholders while maintaining an accessible share price structure.

Regulatory Compliance and Share Rights

The allotment was conducted in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has formally notified both BSE Limited and The National Stock Exchange of India Ltd about this corporate action.

The newly allotted bonus shares will rank pari-passu in all respects with the existing fully paid-up equity shares of the company. This means the bonus shares carry identical rights, including voting rights, dividend entitlements, and other shareholder privileges as the original shares.

Company Profile

Cupid Limited operates as a manufacturer and exporter specializing in male condoms, female condoms, water-based lubricants, and In Vitro Diagnostics (IVD) kits. The company is headquartered at A-68, M.I.D.C. (Malegaon), Sinnar, Nashik, Maharashtra, and trades on both major Indian stock exchanges.

Cupid Limited has informed stock exchanges about the resignation of Ms. Smeeta Bhatkal from her position as Independent Director, effective from the closure of business hours on March 2nd, 2026. The announcement was made through a regulatory filing dated March 6th, 2026, in compliance with SEBI disclosure requirements.

Resignation Details

Ms. Bhatkal, who holds Director Identification Number (DIN) 07363916, submitted her resignation citing full-time professional commitments as the primary reason for her departure. In her resignation letter, she stated that due to these commitments, she would not be able to devote sufficient time to the Board.

Board Committee Impact

With Ms. Bhatkal's resignation, she will also cease to be a member of the company's Audit Committee. This change in board composition will require the company to potentially restructure its committee arrangements to maintain compliance with corporate governance requirements.

Other Directorships

According to the disclosure, Ms. Smeeta Bhatkal currently serves as an Independent Director in Prime Securities Limited, where she also holds the position of Chairperson of the Audit Committee. The company has confirmed that Ms. Bhatkal provided assurance that there are no material reasons for her resignation other than those mentioned in her resignation letter.

Regulatory Compliance

Cupid Limited has fulfilled its disclosure obligations under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company submitted the required information to both BSE Limited and The National Stock Exchange of India Ltd, along with comprehensive details as per SEBI Circular SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024.

Company Background

Cupid Limited operates as a manufacturer and exporter of male condoms, female condoms, water-based lubricants, and In Vitro Diagnostics (IVD) kits. The company is headquartered in Nashik, Maharashtra, with its registered office at A-68, M.I.D.C. (Malegaon), Sinnar, Nashik.